About this trial
This randomized controlled clinical trial aims to evaluate whether reducing the healing interval for implant placement after extraction socket preservation improves clinical and radiographic outcomes compared with the conventional waiting period. Participants requiring single-tooth extraction and implant therapy will be randomly assigned to implant placement either 4 months or 6 months after ridge preservation using the Vega Plus implant system (Klockner).
Clinical and radiographic assessments will be performed at baseline and during follow-up visits. The primary outcome will be the mean change in horizontal alveolar ridge width measured using cone-beam computed tomography (CBCT). Secondary outcomes will include vertical bone height changes measured on CBCT, implant stability measured using resonance frequency analysis (ISQ values), marginal bone level changes assessed on standardized periapical radiographs, and postoperative pain assessed using the Visual Analog Scale (VAS).
The results of this study may contribute to optimizing treatment timing and improving efficiency in implant dentistry while maintaining favorable clinical outcomes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age: ≥ 18 years.
Good general health.
Need of extraction of incisors, canines or premolars due to carious lesion, endodontic complication, root fracture or prosthetic reason.
Presence of three intact socket walls after tooth extraction with a defect of 50% or more of the buccal wall.
Disqualifiers
< 18 years.
Compromised health. Existence of any systemic condition such as uncontrolled diabetes mellitus, cancer, HIV, disorders that compromise wound healing, chronic high dose steroid therapy, intravenous and oral bisphosphonate therapy, bone metabolic diseases, history of irradiation of the head and neck area, or any other immunosuppressive therapy that would contraindicate oral surgical treatment.
Absence of any adjacent teeth or the opposing occluding teeth.
The hopeless tooth is a molar.
Trial design
Parallel
Treatments tested in this trial
Reduced time interval treatment protocol
Procedure/SurgeryParticipants receive treatment phases with a reduced time interval between sessions according to the experimental protocol in order to evaluate whether shortening the interval improves clinical outcomes and treatment efficiency.
Standard time interval treatment protocol
Procedure/SurgeryParticipants receive implant placement after extraction socket preservation following the conventional healing interval used in routine clinical practice.
Treatment groups
Trial outcomes
Primary outcomes
Mean change in horizontal alveolar ridge width (mm) measured by cone-beam computed tomography (CBCT)
Horizontal alveolar ridge width will be measured in millimeters using cone-beam computed tomography (CBCT). Measurements will be obtained at three standardized levels (1 mm, 3 mm, and 5 mm below the crestal bone). Baseline and follow-up CBCT scans will be superimposed, and the mean change in ridge width (mm) between time points will be calculated.
Secondary outcomes
Mean change in vertical alveolar bone height (mm) measured by cone-beam computed tomography (CBCT)
Vertical alveolar bone height will be measured in millimeters using CBCT by determining the distance between the crestal bone (line C) and the apical reference line (line A). Baseline and follow-up CBCT scans will be superimposed, and the mean change in vertical bone height will be calculated.
Mean implant stability quotient (ISQ) measured using resonance frequency analysis (Osstell IDx)
Implant stability will be measured using resonance frequency analysis with the Osstell IDx device. Implant Stability Quotient (ISQ) values will be recorded in mesiodistal and buccolingual directions, and the mean ISQ value will be calculated for each implant.
Mean marginal bone level change (mm) measured on standardized periapical radiographs
Marginal bone levels will be measured using standardized digital periapical radiographs obtained with a parallel technique and individualized film holders. The distance from the implant-abutment junction to the first bone-to-implant contact will be measured mesially and distally, and the mean marginal bone level change will be calculated.
Mean postoperative pain score measured using the Visual Analog Scale (VAS, 0-10)
Postoperative pain will be assessed using the Visual Analog Scale ranging from 0 (no pain) to 10 (worst imaginable pain). The mean pain score will be calculated.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Universidad Catolica Santiago de Guayaquil
Lead sponsor
Klockner Implant System
Collaborator